A cluster-randomised controlled feasibility trial evaluating the Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS).

Neurol Sci · 2025 · PMC11698819 · PMID 39313688

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp -value < 0.001actually significant

This difference was highly significant in a simple two-group comparison ( p -value < 0.001).

also in 132,142 other papers

did not reach statistical significanceno p-value reported

Secondary outcomes Overall, across secondary outcomes there was an average trend towards better performance in the COB-MS group, though as can be seen below many of these differences did not reach statistical significance at week 12 (with the exception of the MFIS, MSQOL-54 and GHQ questionnaires).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.